Board Renewal and key AGM dates
Bendigo, Sep 30, 2022 AEST (ABN Newswire) - Apiam Animal Health Limited (
ASX:AHX) is pleased to announce the appointment of Ms Evonne Collier as a Non-Executive Director to the Company's Board of Directors, with effect from 1 October.
Ms Collier joins the Apiam Board with significant Company Director and strategic leadership experience in many areas including business scale-up, commercial transformation and digital disruption. She also has considerable multinational experience across sales, marketing and Software as a Service in industries spanning pharmaceutical, animal health, MedTech, FinTech, eCommerce/Digital and consumer goods.
"I'm very pleased to welcome Evonne to the Company's Board of Directors. She offers the Apiam Board a skillset that is highly complementary to skillsets of the other directors and her leadership and experience will strengthen the implementation of our Accelerated Growth strategy that we have mapped out over the next two years", said Professor Andrew Vizard, Chair of Apiam.
Ms Collier will stand for election at Apiam's AGM on 24 November 2022.
Also today, Mr Mike van Blommestein has announced that he will retire as a Non-Executive Director of Apiam and not seek re-election when his term expires at the upcoming 2022 AGM on 24 November 2022. Mr van Blommestein has been on the Board of Apiam since the time of the Company's Initial Public Offering in December 2015 and has been the Chair of the Remuneration and Nomination Committee throughout this period.
"Mike has been a distinguished Director of Apiam and in particular made an important contribution to the governance and strategic oversight of our Company. I thank and congratulate Mike on his service and wish him all the best on his future endeavors", said Professor Vizard.
Evonne Collier
Ms Collier has served as a Chair and Non-Executive Director on various boards since 2011 and currently serves as a Director of 4DMedical Limited (ASX:4DX) as well as a number of private and public unlisted companies.
She currently serves as Non-Executive Director of global SaaS analytics company, Sage Automation (Chair of the Digital Products board), SaaS FinTech, Sniip (Remuneration and Nominations Chair), digital dental company, Curae Health (Chair), global eCommerce business, Australian Fitness Supplies (Chair) and Motorama Group Automotive Holdings (Chair of the Marketing and Digital Committee).
Ms Collier was also previously Non-Executive Director of ASX-listed 1300Smiles Limited (ASX:ONT) and Think Childcare Limited (ASX:TNK) prior to its acquisition in 2021.
Ms Collier holds a Master of Business (Marketing, Strategy and Innovation), Bachelor of Arts, Graduate Certificate of Applied Finance, and is a Graduate Member of the Australian Institute of Company Directors.
*To view the AGM Meeting dates, please visit:
https://abnnewswire.net/lnk/9H22AE83
About Apiam Animal Health Limited
Apiam Animal Health Limited (ASX:AHX) is one of Australia's leading rural veterinary businesses made up of more than 80 Veterinary Clinics and 330 highly experienced veterinarians as part of a team of over 1300 dedicated professionals. The majority of Apiam's vet clinics, production animal, and allied businesses have been around a long time, many of them decades and are spread Australia wide reaching into the heart of dairy, beef, sheep and pig country and the regional towns that are at their centre.
Apiam Animal Health is committed to providing best in class care for its clients, the animals in their care and the communities where people live and work. The Company's purpose, to enrich the lives of animals, people and communities, is applied across all businesses from vet clinic to production animal consultancy, logistics and laboratory with vets and allied staff sharing expertise and specialist knowledge. Apiam is focused on meeting the needs of its clients and shaping the future of the industry to deliver best practice animal health and welfare at a local level and nationally.
| ||
|
